Header Logo

Connection

DAVID NELSON to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications DAVID NELSON has written about Drug Evaluation, Preclinical.
DAVID NELSON
Connection Strength
0.022
Drug Evaluation, Preclinical
  1. Chemical screen reveals small molecules suppressing fragile X premutation rCGG repeat-mediated neurodegeneration in Drosophila. Hum Mol Genet. 2012 May 01; 21(9):2068-75.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.